MLC Medical LLC has partnered with Dr. Reddy's Laboratories, a premier global pharmaceutical developer, to broaden immunosuppressive care options in Georgia.

The agreement focuses on the registration and commercialization of Tacrolimus Capsules, USP in 0.5mg and 1mg dosage forms. Tacrolimus represents a frontline calcineurin inhibitor essential for maintaining long-term graft survival in solid-organ transplant recipients.

Collaborating with Dr. Reddy’s ensures Georgian transplant surgeons and nephrologists have access to a proven, globally trusted brand that maintains stringent bioavailability and purity standards.

MLC Medical looks forward to a durable relationship with Dr. Reddy's Laboratories in delivering trusted immunosuppressive medications to patients across the country.